MariMed Inc.
OTC:MRMD
0.3099 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 148.598 | 134.01 | 121.464 | 50.895 | 45.605 | 11.852 | 6.068 | 3.564 | 1.27 | 0.088 | 0.001 | 0.001 | 0.126 |
| Cost of Revenue
| 82.679 | 70.053 | 55.201 | 19.57 | 26.903 | 4.041 | 2.556 | 1.352 | 1.304 | 0.19 | 0.026 | 0.02 | 0.023 |
| Gross Profit
| 65.919 | 63.957 | 66.263 | 31.325 | 18.702 | 7.811 | 3.512 | 2.212 | -0.034 | -0.102 | -0.025 | -0.019 | 0.103 |
| Gross Profit Ratio
| 0.444 | 0.477 | 0.546 | 0.615 | 0.41 | 0.659 | 0.579 | 0.621 | -0.026 | -1.152 | -28.076 | -24.411 | 0.817 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.093 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 44.744 | 35.139 | 35.912 | 15.401 | 12.728 | 11.543 | 3.255 | 1.307 | 1.197 | 0.696 | 0.439 | 0.592 | 0.476 |
| Selling & Marketing Expenses
| 5.977 | 3.736 | 1.625 | 0.411 | 0.37 | 0.292 | 0.13 | 0.293 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 50.721 | 38.875 | 37.537 | 15.812 | 13.097 | 11.835 | 3.385 | 1.601 | 1.197 | 0.696 | 0.439 | 0.592 | 0.476 |
| Other Expenses
| 0 | -0.127 | 0.307 | -0.085 | 2.949 | -0.003 | 0.737 | 0 | 0.367 | 0.02 | 0.094 | 0.164 | 0 |
| Operating Expenses
| 51.534 | 38.875 | 37.537 | 15.812 | 13.097 | 11.835 | 3.385 | 1.601 | 1.657 | 0.716 | 0.533 | 0.756 | 0.476 |
| Operating Income
| 15.08 | 20.369 | 26.863 | 14.531 | 5.604 | -5.356 | 1.206 | 0.612 | -1.691 | -0.817 | -0.558 | -0.775 | -0.374 |
| Operating Income Ratio
| 0.101 | 0.152 | 0.221 | 0.286 | 0.123 | -0.452 | 0.199 | 0.172 | -1.331 | -9.248 | -617.417 | -986.99 | -2.975 |
| Total Other Income Expenses Net
| -21.676 | -0.861 | -3.048 | -10.034 | -40.283 | -9.534 | -1.157 | -0.291 | -0.156 | -6.604 | 0.023 | -0.035 | -0.004 |
| Income Before Tax
| -6.596 | 19.508 | 23.816 | 4.496 | -81.881 | -13.309 | -1.029 | 0.321 | -1.847 | -7.421 | -0.536 | -0.81 | -0.377 |
| Income Before Tax Ratio
| -0.044 | 0.146 | 0.196 | 0.088 | -1.795 | -1.123 | -0.17 | 0.09 | -1.454 | -83.966 | -592.485 | -1,031.261 | -3.005 |
| Income Tax Expense
| 9.411 | 5.894 | 16.192 | 2.067 | -15.363 | -3.586 | 0.677 | 0.867 | -0.425 | -0.146 | 0 | 0 | 0 |
| Net Income
| -16.031 | 13.468 | 7.225 | 2.144 | -66.518 | -13.604 | -1.194 | -0.199 | -1.215 | -7.22 | -0.536 | -0.81 | -0.377 |
| Net Income Ratio
| -0.108 | 0.1 | 0.059 | 0.042 | -1.459 | -1.148 | -0.197 | -0.056 | -0.957 | -81.684 | -592.486 | -1,031.261 | -3.005 |
| EPS
| -0.044 | 0.04 | 0.022 | 0.008 | -0.32 | -0.071 | -0.01 | -0.004 | -0.038 | -0.23 | -0.018 | -0.041 | -1.04 |
| EPS Diluted
| -0.044 | 0.035 | 0.019 | 0.007 | -0.32 | -0.071 | -0.01 | -0.004 | -0.038 | -0.23 | -0.018 | -0.041 | -1.04 |
| EBITDA
| 11.163 | 25.915 | 28.96 | 16.489 | -67.898 | -8.285 | -0.074 | 0.934 | -0.434 | -7.345 | -0.536 | -0.81 | -0.37 |
| EBITDA Ratio
| 0.075 | 0.229 | 0.263 | 0.351 | -0.441 | -0.238 | 0.081 | 0.262 | -0.337 | -9.021 | -642.347 | -942.718 | -2.945 |